Oprelvekin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Oprelvekin, covering 2011-05-04 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation [Phase 2]